Other in vitro analyses suggest that statin antiproliferative action may be due to an effect on cyclin D1 (oncogene) and p27 (tumor suppressor) through up-regulated expression of p27 and down-regulated expression of cyclin D1 in breast cancer cells [43]. The gene discussed is CCND1; the disease is breast carcinoma.